Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash & Current Investments (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Cash & Current Investments for 9 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 16.82% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Dec 2025, up 16.82% year-over-year, with the annual reading at $12.0 million for FY2025, 16.82% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $12.0 million at SANUWAVE Health, up from $9.6 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $12.0 million in Q4 2025, with the low at $106000.0 in Q1 2023.
  • Average Cash & Current Investments over 3 years is $5.1 million, with a median of $3.1 million recorded in 2024.
  • The sharpest move saw Cash & Current Investments soared 2669.81% in 2024, then rose 16.82% in 2025.
  • Over 3 years, Cash & Current Investments stood at $1.8 million in 2023, then skyrocketed by 469.67% to $10.2 million in 2024, then rose by 16.82% to $12.0 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $12.0 million, $9.6 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.